{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:12:50Z","timestamp":1760094770286,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.biopha.2007.02.013","type":"journal-article","created":{"date-parts":[[2007,3,13]],"date-time":"2007-03-13T06:02:54Z","timestamp":1173765774000},"page":"370-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study"],"prefix":"10.1016","volume":"61","author":[{"given":"M.","family":"Astegiano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sapone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Simondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bertolusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bresso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rizzetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2007.02.013_bib1","unstructured":"MacDermott RP, Lichtenstein GR. Integrating anti-tumor necrosis factor-alpha therapy into the management of Crohn's disease: current and future perspectives. Available from URL: http:\/\/www.medscape.com\/viewarticle\/419988?src=search (accessed on 17th Feb, 2006)."},{"key":"10.1016\/j.biopha.2007.02.013_bib2","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2165\/00003495-200565160-00002","article-title":"Biologic therapy for inflammatory bowel disease","volume":"65","author":"Ardizzone","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2007.02.013_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mnm.0000169205.21377.6a","article-title":"Inflammatory bowel diseases: clinical update of practical guidelines","volume":"26","author":"Viscido","year":"2005","journal-title":"Nucl Med Commun"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2007.02.013_bib4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000184852.84558.b2","article-title":"State of the art: IBD therapy and clinical trials in IBD","volume":"11","author":"Isaacs","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 4","key":"10.1016\/j.biopha.2007.02.013_bib5","first-page":"S118","article-title":"Immunopathogenesis of Crohn's disease","volume":"29","author":"MacDonald","year":"2005","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.biopha.2007.02.013_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00129785-200505040-00002","article-title":"Genetic testing in Crohn disease: utility in individualizing patient management","volume":"5","author":"Mascheretti","year":"2005","journal-title":"Am J Pharmacogenomics"},{"key":"10.1016\/j.biopha.2007.02.013_bib7","first-page":"431","article-title":"The pathophysiologic rationale for biological therapies in inflammatory bowel disease","volume":"21","author":"Gordon","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.biopha.2007.02.013_bib8","unstructured":"Feagan BG. What's on the horizon? A view of the management of Crohn's disease over the next decade. Available from URL: http:\/\/www.medscape.com\/viewprogram\/4284_pnt (accessed on 17th Feb, 2006)."},{"key":"10.1016\/j.biopha.2007.02.013_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn's disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1016\/j.biopha.2007.02.013_bib10","first-page":"43","article-title":"New steroids and new salicylates in inflammatory bowel disease: a critical appraisal","volume":"50","author":"Campieri","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2007.02.013_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2036.2003.01661.x","article-title":"Mild to moderate Crohn's disease\u2014defining the basis for a new treatment algorithm","volume":"18","author":"Sandborn","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.biopha.2007.02.013_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/01.MIB.0000171273.09757.f2","article-title":"Postoperative Crohn's disease","volume":"11","author":"Penner","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.biopha.2007.02.013_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2005.02520.x","article-title":"Review article: practical management of inflammatory bowel disease patients taking immunomodulators","volume":"22","author":"Siegel","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.biopha.2007.02.013_bib14","first-page":"443","article-title":"Medical treatment of inflammatory bowel diseases","volume":"21","author":"Van Assche","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.biopha.2007.02.013_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/3-540-37673-9_10","article-title":"TNF blockade: an inflammatory issue","volume":"56","author":"Aggarwal","year":"2006","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.biopha.2007.02.013_bib16","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2165\/00003495-200565150-00014","article-title":"Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis","volume":"65","author":"Siddiqui","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2007.02.013_bib17","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1053\/j.gastro.2004.01.062","article-title":"Advances in treatment of Crohn's disease","volume":"126","author":"Egan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2007.02.013_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/17425247.2.3.451","article-title":"Novel drug delivery strategies for the treatment of inflammatory bowel disease","volume":"2","author":"Kesisoglou","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biopha.2007.02.013_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2036.1998.00299.x","article-title":"Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis","volume":"12","author":"Campieri","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"8272","key":"10.1016\/j.biopha.2007.02.013_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(82)91747-0","article-title":"Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome of hypothalamic pituitary adrenal suppression","volume":"1","author":"Kumana","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2007.02.013_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gtc.2004.02.003","article-title":"General principles of medical therapy of inflammatory bowel disease","volume":"33","author":"Friedman","year":"2004","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.biopha.2007.02.013_bib22","first-page":"90","article-title":"Treatment of Crohn's disease","volume":"47","author":"Hoffmann","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.biopha.2007.02.013_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00004836-200012000-00004","article-title":"Update in medical treatment of Crohn's disease","volume":"31","author":"Regueiro","year":"2000","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2007.02.013_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ibd.3780070503","article-title":"Conventional treatment of Crohn's disease: objectives and outcomes","volume":"7","author":"Rutgeerts","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.biopha.2007.02.013_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11894-005-0079-9","article-title":"Advances in therapeutic approaches to ulcerative colitis and Crohn's disease","volume":"7","author":"Travis","year":"2005","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.biopha.2007.02.013_bib26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2165\/00003495-200464100-00004","article-title":"Maintenance of remission in Crohn's disease: current and emerging therapeutic options","volume":"64","author":"Brookes","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.biopha.2007.02.013_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1572-0241.2003.04010.x","article-title":"Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries","volume":"99","author":"Lichtenstein","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.biopha.2007.02.013_bib28","first-page":"CD003715","article-title":"Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease","author":"Akobeng","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopha.2007.02.013_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1179\/acb.2004.045","article-title":"Management of ulcerative colitis and Crohn's disease","volume":"59","author":"Baert","year":"2004","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.biopha.2007.02.013_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1572-0241.2005.41598.x","article-title":"Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience","volume":"100","author":"Bajaj","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.biopha.2007.02.013_bib31","first-page":"CD000296","article-title":"Budesonide for induction of remission in Crohn's disease","author":"Otley","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 4","key":"10.1016\/j.biopha.2007.02.013_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2036.2004.02048.x","article-title":"Review article: aminosalicylates in inflammatory bowel disease","volume":"20","author":"Hanauer","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.biopha.2007.02.013_bib33","first-page":"2565","article-title":"5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease","volume":"123","author":"Moum","year":"2003","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.biopha.2007.02.013_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042737-200402000-00014","article-title":"Side effects of azathioprine in patients with Crohn's disease","volume":"16","author":"De Jong","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2007.02.013_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00054725-199808000-00009","article-title":"Which immunosuppressors do you use to treat Crohn's disease and ulcerative colitis? In which order of priority and how worried are you about toxicity?","volume":"4","author":"Scholmerich","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.biopha.2007.02.013_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00042737-200401000-00008","article-title":"European Collaborative Research Group on Budesonide in Paediatric IBD","volume":"16","author":"Escher","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2007.02.013_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1067\/mpd.2002.119992","article-title":"Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn's disease in children","volume":"140","author":"Levine","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.biopha.2007.02.013_bib38","first-page":"248","article-title":"A\u00a0comparison of budesonide and prednisone for the treatment of active\u00a0pediatric Crohn disease","volume":"36","author":"Levine","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.biopha.2007.02.013_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00001574-200407000-00004","article-title":"Biomarkers in inflammatory bowel disease","volume":"20","author":"Beaven","year":"2004","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.biopha.2007.02.013_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ncpgasthep0359","article-title":"The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases","volume":"2","author":"Vermeire","year":"2005","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2007.02.013_bib41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.biopha.2007.02.013_bib42","first-page":"69","article-title":"Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic","volume":"89","author":"Cabrera-Abreu","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.biopha.2007.02.013_bib43","first-page":"52","article-title":"Assessment of inflammatory activity in Crohn's disease","volume":"45","author":"Lamers","year":"1994","journal-title":"Neth J Med"},{"key":"10.1016\/j.biopha.2007.02.013_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/gut.38.1.99","article-title":"Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease","volume":"38","author":"Mahmud","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2007.02.013_bib45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00004836-198612000-00011","article-title":"Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease","volume":"8","author":"Sachar","year":"1986","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.biopha.2007.02.013_bib46","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00004836-199012000-00009","article-title":"Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ileitis versus colitis","volume":"12","author":"Sachar","year":"1990","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.biopha.2007.02.013_bib47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/gut.41.2.209","article-title":"Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group","volume":"41","author":"Campieri","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2007.02.013_bib48","first-page":"905","article-title":"Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German\/Austrian Budesonide Study Group","volume":"8","author":"Gross","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.biopha.2007.02.013_bib49","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1365-2036.2000.00867.x","article-title":"Budesonide in the treatment of Crohn's disease: a meta-analysis","volume":"14","author":"Papi","year":"2000","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333220700025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333220700025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:39:23Z","timestamp":1760092763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333220700025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S075333220700025X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2007.02.013","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2007.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}